直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 114862
著者
Kato, Yoshikane Kanaiso Hospital
板東, 浩 Kanaiso Hospital|Tokushima University KAKEN研究者をさがす
Yamashita, Hisako Kanaiso Hospital
Yada, Seigo Kanaiso Hospital
Tokuhara, Shunsuke Kanaiso Hospital
Tokuhara, Hatsue Kanaiso Hospital
Mutsuda, Teruo Kanaiso Hospital
キーワード
Xultophy®
glucagon-like peptide-1 receptor agonist (GLP-1 RA)
Japan LCD promotion association (JLCDPA)
Carpal tunnel syndrome (CTS)
oral hyperglycemic agents (OHAs)
資料タイプ
学術雑誌論文
抄録
Diabetes mellitus causes macrovascular, microvascular angiopathy, and increased cancer risk. Authors et al. have continued clinical practice and research on diabetes cases. Current case is impressive 79-year-old female with various diseases. They include asthma and COPD, steroid intake for years, sleep apnea syndrome (SAS), Continuous Positive Airway Pressure (CPAP) therapy, tongue cancer, arteriosclerosis, bone complications, Carpal tunnel syndrome (CTS), and so on. When she developed hyperglycemia with 9.0% of HbA1c, Xultophy® was started. It contains insulin degludec and liraglutide which is Glucagon-like peptide-1 receptor agonist (GLP-1 RA). HbA1c values decreased as 7.9%, 7.3%, 6.9%, 6.5% in 1-4 months, with remarkable effect. The satisfactory efficacy may be from double agents of Xultophy® or probable secondary diabetes due to continuation of steroid of the case. This report will be expected to be some reference in the future diabetic research development.
掲載誌名
MOJ Clinical & Medical Case Reports
ISSN
2381179X
出版者
MedCrave Publishing
10
2
開始ページ
48
終了ページ
51
発行日
2020-04-30
権利情報
©2020 Kato et al. This is an open access article distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and build upon your work non-commercially.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系